Company / Working Capital
LEXICON PHARMACEUTICALS, INC. Working Capital History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$81.0M
FY2025
5-year range
$81.0M / $200.9M
FY2021-FY2025
Trend
-59.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 10 years, ranging from $81M in FY2025 to $409M in FY2015.
Based on SEC 10-K filings.
$81M in FY2025 with a 10-year CAGR of -15.0%.
Declined from $145M to $81M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -15.0%
Key checks
Key Insights
- In FY2025, working capital decreased 59.7% year-over-year.
- Peak working capital was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $81.0M | -59.7% |
| FY2024 | $200.9M | +38.6% |
| FY2023 | $145.0M | +23.2% |
| FY2019 | $117.7M | -13.8% |
| FY2018 | $136.6M | -31.0% |
| FY2017 | $197.9M | +2.4% |
| FY2016 | $193.2M | -52.8% |
| FY2015 | $409.4M | +26.4% |
| FY2014 | $324.0M | +181.1% |
| FY2013 | $115.3M | -45.8% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026